Targeted News Service

Experimental hookworm vaccine shows promising protection in phase 2 human trial
March 18, 2026

HOUSTON, Texas, March 18 -- The Baylor College of Medicine posted the following news:

* * *

Experimental hookworm vaccine shows promising protection in phase 2 human trial

*

Researchers at the George Washington University School of Medicine and Health Sciences in partnership with Baylor College of Medicine report encouraging results from a phase 2 clinical trial evaluating a candidate vaccine to prevent hookworm infection - one of the world . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form